|
|
Previous Article | Table of Contents | Next Article 
In situ-generated thrombin is the only enzyme that effectively activates
factor VIII and factor V in thromboplastin-activated plasma
J Pieters, T Lindhout and HC Hemker
Department of Biochemistry, University of Limburg, Maastricht, The
Netherlands.
We investigated the activation of the nonenzymatic protein cofactors factor
VIII and factor V in plasma when coagulation was initiated by
thromboplastin. With sensitive bioassays, we were able to measure
specifically the generation of activated factor VIII and activated factor V
in plasma. Our results showed that when plasma was triggered with a
relatively high concentration of thromboplastin, factor VIII and factor V
were completely activated at the clotting time of plasma. However, when the
generation of thrombin, but not that of factor Xa, was delayed by addition
of hirudin to the plasma, factor Va was generated only at the time thrombin
generation overcame the hirudin inhibition. In addition, generation of
factor VIIIa correlated with thrombin generation and not with factor Xa
generation. Furthermore, addition of large amounts of factor Xa to
hirudinized plasma did not show detectable factor VIII or factor V
activation. We concluded that in plasma activated with thromboplastin the
enzyme responsible for activation of factor V and factor VIII is thrombin,
not factor Xa.
Volume 74,
Issue 3,
pp. 1021-1024,
08/15/1989
Copyright © 1989 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. L. Newell and P. J. Fay
Proteolysis at Arg740 Facilitates Subsequent Bond Cleavages during Thrombin-catalyzed Activation of Factor VIII
J. Biol. Chem.,
August 31, 2007;
282(35):
25367 - 25375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Bukys, P. Y. Kim, M. E. Nesheim, and M. Kalafatis
A Control Switch for Prothrombinase: CHARACTERIZATION OF A HIRUDIN-LIKE PENTAPEPTIDE FROM THE COOH TERMINUS OF FACTOR Va HEAVY CHAIN THAT REGULATES THE RATE AND PATHWAY FOR PROTHROMBIN ACTIVATION
J. Biol. Chem.,
December 22, 2006;
281(51):
39194 - 39204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jesty and E. Beltrami
Positive Feedbacks of Coagulation: Their Role in Threshold Regulation
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2005;
25(12):
2463 - 2469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nogami, Q. Zhou, H. Wakabayashi, and P. J. Fay
Thrombin-catalyzed activation of factor VIII with His substituted for Arg372 at the P1 site
Blood,
June 1, 2005;
105(11):
4362 - 4368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tobu, O. Iqbal, H. L. Messmore, Q. Ma, D. A. Hoppensteadt, and J. Fareed
Influence of Different Anticoagulant Agents on Fibrinopeptide A Generation
Clinical and Applied Thrombosis/Hemostasis,
October 1, 2003;
9(4):
273 - 292.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Mann, S. Butenas, and K. Brummel
The Dynamics of Thrombin Formation
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2003;
23(1):
17 - 25.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Monroe, M. Hoffman, and H. R. Roberts
Platelets and Thrombin Generation
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2002;
22(9):
1381 - 1389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Butenas, K. M. Cawthern, C. van't Veer, M. E. DiLorenzo, J. B. Lock, and K. G. Mann
Antiplatelet agents in tissue factor-induced blood coagulation
Blood,
April 15, 2001;
97(8):
2314 - 2322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Abendschein, P. K. Baum, P. Verhallen, P. R. Eisenberg, M. E. Sullivan, and D. R. Light
A Novel Synthetic Inhibitor of Factor Xa Decreases Early Reocclusion and Improves 24-h Patency after Coronary Fibrinolysis in Dogs
J. Pharmacol. Exp. Ther.,
April 13, 2001;
296(2):
567 - 572.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. A. Merlini, D. Ardissino, R. D. Rosenberg, E. Colombi, P. Agricola, L. Oltrona, F. Ottani, M. Galvani, K. A. Bauer, B. Bottasso, et al.
In Vivo Thrombin Generation and Activity During and After Intravenous Infusion of Heparin or Recombinant Hirudin in Patients With Unstable Angina Pectoris
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2000;
20(9):
2162 - 2166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H. M. Senden, T. M. A. A. Jeunhomme, J. W. M. Heemskerk, R. Wagenvoord, C. van't Veer, H. C. Hemker, and W. A. Buurman
Factor Xa Induces Cytokine Production and Expression of Adhesion Molecules by Human Umbilical Vein Endothelial Cells
J. Immunol.,
October 15, 1998;
161(8):
4318 - 4324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Cawthern, C. van `t Veer, J. B. Lock, M. E. DiLorenzo, R. F. Branda, and K. G. Mann
Blood Coagulation in Hemophilia A and Hemophilia C
Blood,
June 15, 1998;
91(12):
4581 - 4592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Merlini, D. Ardissino, K. A. Bauer, L. Oltrona, A. Pezzano, B. Bottasso, R. D. Rosenberg, and P. M. Mannucci
Persistent Thrombin Generation During Heparin Therapy in Patients With Acute Coronary Syndromes
Arterioscler. Thromb. Vasc. Biol.,
July 1, 1997;
17(7):
1325 - 1330.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. A. Prager, D. R. Abendschein, C. R. McKenzie, and P. R. Eisenberg
Role of Thrombin Compared With Factor Xa in the Procoagulant Activity of Whole Blood Clots
Circulation,
August 15, 1995;
92(4):
962 - 967.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. M. Regan and P. J. Fay
Cleavage of Factor VIII Light Chain Is Required for Maximal Generation of Factor VIIIa Activity
J. Biol. Chem.,
April 14, 1995;
270(15):
8546 - 8552.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|